Stent-Induced [Ga]Ga-FAPI Diffuse Expression in a Patient with Pancreatic Cancer: Navigating Non-oncologic Challenges.
作者信息
Al-Ibraheem Akram, Sweedat Deya' Aldeen, Abdlkadir Ahmed Saad, Stanimirović Dragi, Dadgar Habibollah
机构信息
Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, 11941 Amman Jordan.
Schoold of Medicine, University of Jordan, Amman, 11942 Jordan.
出版信息
Nucl Med Mol Imaging. 2024 Aug;58(5):317-318. doi: 10.1007/s13139-024-00844-7. Epub 2024 Jan 31.
Abstract
摘要
相似文献
1
Stent-Induced [Ga]Ga-FAPI Diffuse Expression in a Patient with Pancreatic Cancer: Navigating Non-oncologic Challenges.
Nucl Med Mol Imaging. 2024 Aug;58(5):317-318. doi: 10.1007/s13139-024-00844-7. Epub 2024 Jan 31.
2
68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
Clin Nucl Med. 2023 Sep 1;48(9):e420-e430. doi: 10.1097/RLU.0000000000004751. Epub 2023 Jun 23.
3
Comparison of F-fluorodeoxyglucose PET and Ga-fibroblast Activation Protein Inhibitor PET in Head and Neck Cancers: A Systematic Review and Meta-analysis.
Acad Radiol. 2025 Mar 10. doi: 10.1016/j.acra.2025.02.038.
4
Same-day dual-tracer PET/CT imaging with [ Ga]Ga-FAPI-04 following [F]FDG finds answers in patients presenting with negative or equivocal [F]FDG.
Ann Nucl Med. 2025 Jul 4. doi: 10.1007/s12149-025-02080-1.
5
[Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis.
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):908-920. doi: 10.1007/s00259-022-06021-2. Epub 2022 Nov 3.
6
Application Value of 68 Ga-FAPI PET/CT in the Evaluation of Myelofibrotic Diseases.
Clin Nucl Med. 2024 May 1;49(5):404-408. doi: 10.1097/RLU.0000000000005120. Epub 2024 Feb 28.
7
[Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [F]-FDG PET MRI/CT: a meta-analysis.
Eur J Med Res. 2023 Jan 18;28(1):34. doi: 10.1186/s40001-023-00997-9.
8
The Contribution of 68 Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer.
Clin Nucl Med. 2024 Oct 1;49(10):e485-e491. doi: 10.1097/RLU.0000000000005394. Epub 2024 Jul 31.
9
Diagnostic value of F-FDG and Ga-FAPI in head and neck cancers: A systematic review and meta-analysis.
Hell J Nucl Med. 2025 Jan-Apr;28(1):44-60. doi: 10.1967/s002449912786. Epub 2025 Apr 7.
10
68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
Clin Nucl Med. 2024 May 1;49(5):409-418. doi: 10.1097/RLU.0000000000005112. Epub 2024 Mar 6.
引用本文的文献
1
First Clinical Experience of Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls.
Diagnostics (Basel). 2025 Jan 19;15(2):218. doi: 10.3390/diagnostics15020218.
2
Intense fibroblast activation protein inhibitor localization around the site of embolized gastroduodenal artery in a patient with metachronous pancreatic adenocarcinoma: A potential pitfall in positron imaging.
Acta Radiol Open. 2024 Dec 9;13(12):20584601241307350. doi: 10.1177/20584601241307350. eCollection 2024 Dec.
本文引用的文献
1
68 Ga-FAPI PET/CT Imaging : Unveiling the Hidden Pitfalls.
Clin Nucl Med. 2023 Nov 1;48(11):965-966. doi: 10.1097/RLU.0000000000004802. Epub 2023 Sep 21.
2
68 Ga-FAPI PET/CT Provides a Clear Picture of a Klatskin Tumor That 18 F-FDG PET/CT Missed.
Clin Nucl Med. 2023 Jun 1;48(6):e313-e315. doi: 10.1097/RLU.0000000000004652. Epub 2023 Apr 24.
3
Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Clin Nucl Med. 2023 Jun 1;48(6):e281-e288. doi: 10.1097/RLU.0000000000004641. Epub 2023 Apr 5.
4
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.
Semin Nucl Med. 2023 Sep;53(5):694-705. doi: 10.1053/j.semnuclmed.2023.02.001. Epub 2023 Feb 20.
5
Acute Pancreatitis after Biliary and Pancreatic Stent Removal with a Forward-Viewing Endoscope.
Case Rep Gastroenterol. 2021 Sep 6;15(3):785-790. doi: 10.1159/000518862. eCollection 2021 Sep-Dec.
Zotero 插件